Skip to content

Hearing investigation of the lassitude for the cancer connection to the patient who enforced anticancer agent treatment in the municipal Hakodate hospital obstetrics and gynecology department

Hearing investigation of the lassitude for the cancer connection to the patient who enforced anticancer agent treatment in the municipal Hakodate hospital obstetrics and gynecology department - Hearing investigation of the lassitude for the cancer connection to the patient who enforced anticancer agent treatment in the municipal Hakodate hospital obstetrics and gynecology department

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000021312
Enrollment
50
Registered
2016-04-01
Start date
2016-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients who underwent anti-cancer drug treatment for gynecological cancer

Interventions

None listed

Sponsors

Hakodate Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Anti-cancer drug treatment enforcement in Obstetrics and Gynecology

Exclusion criteria

Exclusion criteria: Anti-cancer drug treatment not yet come into force at the Department of Obstetrics and Gynecology

Design outcomes

Primary

MeasureTime frame
The extent of the malaise

Countries

Japan

Contacts

Public ContactYukio Sakata

Hakodate Municipal Hospital Pharmaceutical department

y-sakata@hospital.hakodate.hokkaido.jp0138-43-2000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026